Your browser is no longer supported. Please, upgrade your browser.
Settings
NVS Novartis AG daily Stock Chart
NVS [NYSE]
Novartis AG
Index- P/E13.95 EPS (ttm)5.87 Insider Own9.30% Shs Outstand2.59B Perf Week-2.05%
Market Cap212.30B Forward P/E14.74 EPS next Y5.55 Insider Trans0.28% Shs Float2.50B Perf Month3.98%
Income13.79B PEG1.86 EPS next Q1.30 Inst Own11.00% Short Float0.10% Perf Quarter5.45%
Sales52.24B P/S4.06 EPS this Y15.20% Inst Trans-0.50% Short Ratio1.44 Perf Half Y-4.31%
Book/sh33.01 P/B2.48 EPS next Y6.64% ROA10.20% Target Price89.75 Perf Year-2.70%
Cash/sh5.07 P/C16.15 EPS next 5Y7.49% ROE18.80% 52W Range72.30 - 94.19 Perf YTD-2.54%
Dividend2.98 P/FCF58.21 EPS past 5Y-3.50% ROI7.10% 52W High-12.83% Beta0.90
Dividend %3.64% Quick Ratio0.90 Sales past 5Y-0.70% Gross Margin67.00% 52W Low13.56% ATR0.87
Employees125000 Current Ratio1.10 Sales Q/Q7.70% Oper. Margin29.00% RSI (14)56.41 Volatility0.80% 0.78%
OptionableYes Debt/Eq0.42 EPS Q/Q296.80% Profit Margin26.50% Rel Volume0.93 Prev Close81.83
ShortableYes LT Debt/Eq0.30 EarningsJul 18 BMO Payout45.70% Avg Volume1.81M Price82.11
Recom2.70 SMA20-1.00% SMA504.33% SMA2000.72% Volume1,639,202 Change0.34%
May-29-18Downgrade HSBC Securities Buy → Hold
May-25-18Upgrade Credit Suisse Underperform → Neutral
Jan-25-18Reiterated Leerink Partners Outperform $93 → $100
Dec-06-17Downgrade BofA/Merrill Neutral → Underperform
Jul-26-17Upgrade Morgan Stanley Underweight → Overweight
Jul-05-17Downgrade Credit Suisse Neutral → Underperform
Mar-09-17Initiated Liberum Buy
Mar-08-17Upgrade Societe Generale Hold → Buy
Mar-07-17Downgrade Exane BNP Paribas Neutral → Underperform
Jan-11-17Downgrade Credit Suisse Outperform → Neutral
Nov-10-16Upgrade Argus Hold → Buy
Oct-10-16Reiterated Chardan Capital Markets Buy $95 → $92
Sep-20-16Initiated Chardan Capital Markets Buy $95
Apr-12-16Downgrade Morgan Stanley Equal-Weight → Underweight
Mar-23-16Downgrade Leerink Partners Outperform → Mkt Perform
Jun-22-15Upgrade Bryan Garnier Neutral → Buy
Nov-16-09Initiated Deutsche Securities Buy
Nov-12-09Initiated Barclays Capital Underweight $48
Sep-30-09Upgrade Citigroup Hold → Buy
Sep-15-09Upgrade Jefferies & Co Hold → Buy
Aug-16-18 01:25PM  FDA approves first rival generic EpiPen, sending Teva shares up 6% MarketWatch
07:00AM  Market Morning: Gene Therapy Deregulation, Amazon to the Movies, SEC On Musks Tail Market Exclusive
Aug-14-18 02:24PM  Three expansions, 923 jobs: Durham County approves incentives packages American City Business Journals
01:28PM  Array BioPharma Inc. (ARRY) Q4 2018 Earnings Conference Call Transcript Motley Fool
09:49AM  Regeneron's 12-Week Eylea Dose Gets CRL From FDA for Wet AMD Zacks
05:47AM  Novartis recruits new compliance head from Siemens after ethics stumbles Reuters
Aug-13-18 02:52PM  Mixed Reviews For Allakos As Sell-Side Starts Coverage Of Biotech Benzinga
Aug-07-18 04:50PM  This Midcap Biotech Popped Nearly 20% On Hope In Cancer, Inflammation Investor's Business Daily
Aug-06-18 04:15PM  Can These Biotech Companies Catch Novartis, Gilead In CAR-T? Investor's Business Daily
04:08PM  Does Bausch Face A Reckoning? 5 Key Issues To Look For In Its Earnings Investor's Business Daily
09:09AM  The Zacks Analyst Blog Highlights: Pfizer, Bristol-Myers, Sanofi, Glaxo and Novartis Zacks
08:56AM  Why Novartis Stock Gained 11% in July Motley Fool
Aug-05-18 07:42PM  How China Is Evolving From a Maker of Copycat Medicines Into a Producer of Complex Drugs The Wall Street Journal
08:00AM  J&J Bets on Chinese Startup That Uses Llama DNA to Fight Cancer The Wall Street Journal
Aug-03-18 04:00PM  Teva Chief Says Generic Prices Are Improving Will Its Stock Also Do So? Investor's Business Daily
02:46PM  Avoid Treating Biogen Like a Speculative Drug Stock InvestorPlace
12:07PM  Aduro (ADRO) Q2 Loss Narrower Than Expected, Revenues Miss Zacks
Aug-02-18 04:43PM  Healthcare Bulls Get a Second Dose of Earnings-Driven Profits TheStreet.com
11:47AM  Conatus' (CNAT) Q2 Loss Narrows, Revenues Lag Marginally Zacks
Aug-01-18 01:45PM  More drugmakers build Brexit stockpiles as EU agency faces exodus Reuters
09:38AM  Sanofi, Novartis latest to stockpile drugs in case of no-deal Brexit Reuters
09:35AM  Sanofi, Novartis latest to stockpile drugs in case of no-deal Brexit Reuters
09:34AM  Biotech Stock Roundup: Celgene, Amgen, Vertex Impress in Q2, Gilead's CEO to Exit Zacks
Jul-31-18 12:15PM  3 Biotech Stocks in Focus on Tuesday ACCESSWIRE
Jul-27-18 04:34PM  Antibiotics market wipes out 80 jobs at Peninsula company a month after its 1st drug approval American City Business Journals
01:00PM  1 week until the deadline for Disrupt SF 2018s Hackathon + new sponsor prizes TechCrunch
09:23AM  Amgen (AMGN) Q2 Earnings & Sales Beat Estimates, View Up Zacks
Jul-26-18 07:30AM  Initiating Free Research Reports on Pfizer and Three Other Drug Makers Equities ACCESSWIRE
Jul-25-18 06:02PM  Why AnaptysBio Rose 10.5% Today Motley Fool
05:01PM  Gilead's Earnings Fail to Impress TheStreet.com
09:15AM  Glaxo (GSK) Beats on both Earnings and Revenue in Q2 Zacks
Jul-24-18 11:54AM  Novartis's Cultural Revolution Will Be AI-Enabled and Desk-Free Bloomberg
Jul-23-18 04:20PM  What's in the Cards for Glaxo (GSK) This Earnings Season? Zacks
10:45AM  Tilrays IPO Looks Badly Overpriced And It Might Not Matter InvestorPlace
09:26AM  Should GlaxoSmithKline Break Up? Motley Fool
09:01AM  The Zacks Analyst Blog Highlights: Microsoft, Novartis, Goldman Sachs, Starbucks and General Motors Zacks
Jul-21-18 08:44AM  Canaccord Previews Biotech Catalysts In The Second Half: Neurological Drugs In Focus Benzinga
Jul-20-18 05:43PM  Pfizer gets FDA approval for drug similar to Amgen's Neupogen MarketWatch
11:11AM  Swiss, German drugmakers join U.S. price freeze Reuters
11:02AM  Top Research Reports for Microsoft, Novartis & Goldman Sachs Zacks
10:48AM  Swiss, German drugmakers join U.S. price freeze Reuters
08:59AM  Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, FDA Approvals Zacks
07:30AM  Three Key Takeaways From Healthcare Earnings Season TheStreet.com
07:00AM  Free Post Earnings Research Report: Novartis Net Sales Jumped 7%; Non-GAAP EPS Advanced 6% ACCESSWIRE
Jul-19-18 06:52PM  Novartis wont raise drug prices in US Fox Business Videos
06:43PM  Novartis' (NVS) Kisqali Gets FDA Nod for Label Expansion Zacks
11:31AM  Novartis Sues to Block Generic Sales of Top Drug Gilenya for MS Bloomberg
09:14AM  Benzinga's Daily Biotech Pulse: Novartis Licenses Skin Drug, 2 Stocks To Debut Benzinga
08:33AM  [$$] Novartis, MorphoSys and Galapagos Shares Rise on Drug Deal The Wall Street Journal
06:52AM  Trump thanks Novartis, Pfizer for not raising drug prices Reuters
02:29AM  Novartis to Pay as Much as $1 Billion for Rights to Skin Drug Bloomberg
02:25AM  Novartis to pay 95 mln euros to Galapagos, MorphoSys for skin drug Reuters
Jul-18-18 08:00PM  [$$] Novartis Wont Raise U.S. Drug Prices This Year The Wall Street Journal
04:27PM  Novartis Q2 Earnings Miss, Sales Top on Cosentyx, Entresto Zacks
03:07PM  5 Big Biotech Stories to Watch TheStreet.com
12:54PM  Novartis hints at 2018 outlook hike despite drug price freeze Reuters
12:32PM  Novartis Earnings: 'A Focused Company Wins,' Says CEO Barrons.com
11:08AM  Novartis AG (NVS) Q2 2018 Earnings Conference Call Transcript Motley Fool
10:50AM  [$$] Novartis Won't Raise U.S. Drug Prices This Year The Wall Street Journal
08:42AM  Benzinga's Daily Biotech Pulse: Novartis Earnings, J&J's HIV Combo Clears FDA Hurdle, Cara To Offer Shares Benzinga
06:53AM  Novartis joins Pfizer in halting U.S. drug price hikes Reuters
05:02AM  Novartis: 2Q Earnings Snapshot Associated Press
04:50AM  Novartis CEO Says It's `Prudent' to Pull Back From Further Price Increases Bloomberg Video
04:50AM  Novartis CEO Says It's `Prudent' to Pull Back From Further Price Increases Bloomberg
04:20AM  Novartis puts brakes on price hikes, bowing to U.S. pressure Reuters
03:16AM  Swiss drugs giant Novartis says profit up as spinoff looms Associated Press
02:36AM  Novartis Joins Pfizer in Holding Line on Drug Prices in U.S. Bloomberg
02:36AM  Novartis CEO Says Drugmaker Won't Raise U.S. Prices This Year Bloomberg
02:11AM  [$$] Novartis Confirms Outlook The Wall Street Journal
01:21AM  Novartis Blockbuster Drug Rebounds, Easing Generics Pressure Bloomberg
Jul-17-18 10:49PM  [$$] Chinese Hit Movie Dying to Survive Injects Urgency in Drug-Price Push The Wall Street Journal
10:13PM  Novartis (NVS) Stock Flat Ahead of Earnings: What To Watch Zacks
04:04PM  Earnings Outlook For Novartis Benzinga
12:33PM  GlaxoSmithKline Is More Than Just a 5% Dividend Income Play InvestorPlace
Jul-16-18 08:15AM  Is a Surprise in the Cards for Novartis in Q2 Earnings? Zacks
08:01AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Novartis, UnitedHealth and Microsoft Zacks
Jul-13-18 08:04PM  [$$] Novartis Played Down Ties to Trump Lawyer Michael Cohen, Report Says The Wall Street Journal
04:49PM  [$$] Novartis Communicated With Trump's Lawyer for Months, Report Says The Wall Street Journal
03:09PM  Novartis Looks to Exit Antibacterial, Antiviral Program Zacks
01:35PM  Dems: Novartis deal with Cohen sought access to policymakers Associated Press
11:47AM  Novartis Account of Cohen Connection Assailed by U.S. Senators Bloomberg
09:45AM  AT&T failed to provide requested documents to Senate probe of payments made to Michael Cohen MarketWatch
09:21AM  Novartis disputes U.S. senators' report on Cohen contract Reuters
09:16AM  Novartis disputes U.S. senators' report on Cohen contract Reuters
08:43AM  JNJ vs. NVS: Which Stock is Better Pre Q1 Earnings? Zacks
08:36AM  Novartis disputes U.S. senators' report over Cohen contract Reuters
08:33AM  Cohen's Novartis Work Was Broader Than Reported, Democrats Say Bloomberg
08:33AM  Cohen Pitched Novartis Russia-Tied Investment, Democrats Say Bloomberg
08:15AM  Better Know Biotech: Regenxbio Inc. Motley Fool
12:00AM  Superbugs Win Another Round as Big Pharma Leaves Antibiotics Bloomberg
Jul-12-18 09:05PM  [$$] Democrats allege Trump lawyer had broad contacts with Novartis Financial Times
08:59AM  3 Gene Therapy Stocks Investors Can Bet on in Rest of 2018 Zacks
07:15AM  Novartis launches the Galaxies of Hope app, a digital experience for the Neuroendocrine Tumor (NET) cancer community PR Newswire
Jul-11-18 05:53PM  Novartis Exits Antibiotics Research, Cuts 140 Jobs in Bay Area Bloomberg
05:49PM  Once with lofty plans, Novartis now closing East Bay unit, cutting 140 jobs American City Business Journals
01:00PM  Removing the Hidden Obstacle Holding Back New Cancer Therapies Bloomberg
04:47AM  Moody's: European pharma sector earnings poised to rise into 2019 as new drugs come to market Moody's
Jul-10-18 04:47PM  Kate Warne- Investment Strategist Edward Jones Yahoo Finance Video
02:46PM  Drugmakers Cancel Price Hikes After California Law Takes Effect Bloomberg
Jul-09-18 08:58AM  [$$] China vows to accelerate cancer drug price cuts Financial Times
Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. The company's Innovative Medicines segment offers patented prescription medicines to enhance health outcomes for patients and health-care providers. This segment also commercializes products in the areas of oncology and rare diseases, ophthalmology, immunology and dermatology, neuroscience, respiratory, cardio-metabolic, and established medicines. The Sandoz segment provides active ingredients and finished dosage forms of pharmaceuticals in the areas of cardiovascular, central nervous system, dermatology, gastrointestinal and hormonal therapies, metabolism, oncology, ophthalmic, pain, and respiratory; active pharmaceutical ingredients and intermediates primarily antibiotics; protein or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. The Alcon segment offers eye care products, such as eye care devices for cataract, retinal, glaucoma, and refractive surgery, as well as intraocular lenses to treat cataracts and refractive errors; viscoelastics, surgical solutions, surgical packs, and other disposable products for cataract and vitreoretinal surgery; and contact lenses, as well as contact lens care products, including multi-purpose and hydrogen-peroxide based solutions, rewetting drops, and daily protein removers. Novartis AG has collaboration agreements with Xencor; Surface Oncology; Intellia Therapeutics; Caribou Biosciences; Bristol-Myers Squibb; IBM Watson Health; Amgen; Allergan plc; Science 37, Inc.; Bill & Melinda Gates Foundation; and PEAR Therapeutics. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Novartis Bioventures Ltd10% OwnerAug 13Sale2.361,6003,7762,440,713Aug 14 05:05 PM
Novartis Bioventures Ltd10% OwnerAug 10Sale2.445,61513,7012,442,313Aug 14 05:05 PM
Novartis Bioventures Ltd10% OwnerAug 09Sale2.482355832,447,928Aug 10 04:29 PM
Novartis Bioventures Ltd10% OwnerAug 08Sale2.781,0002,7802,448,163Aug 10 04:29 PM
Novartis Bioventures Ltd10% OwnerAug 07Sale2.971,7395,1652,449,163Aug 08 04:21 PM
Novartis Bioventures Ltd10% OwnerAug 06Sale3.022,9428,8852,450,902Aug 08 04:21 PM
Novartis Bioventures Ltd10% OwnerAug 02Sale3.334,70215,6582,453,844Aug 06 04:22 PM
Novartis Bioventures Ltd10% OwnerAug 01Sale3.228,18126,3432,458,546Aug 02 04:33 PM
Novartis Bioventures Ltd10% OwnerJul 31Sale3.074,50013,8152,466,727Aug 02 04:33 PM
Novartis Bioventures Ltd10% OwnerJul 30Sale3.272,0006,5402,471,227Jul 31 04:16 PM
Novartis Bioventures Ltd10% OwnerJul 27Sale3.386,45821,8282,473,227Jul 31 04:16 PM
Novartis Bioventures Ltd10% OwnerJul 26Sale3.637,93728,8112,479,685Jul 27 04:21 PM
Novartis Bioventures Ltd10% OwnerJul 25Sale3.8412,46047,8462,487,622Jul 27 04:21 PM
Novartis Bioventures Ltd10% OwnerJul 24Sale4.117002,8772,500,082Jul 25 04:35 PM
Novartis Bioventures Ltd10% OwnerJul 23Sale4.2530,600130,0502,500,782Jul 25 04:35 PM
Novartis Bioventures Ltd10% OwnerJul 17Sale4.7112,50058,8752,531,382Jul 18 04:17 PM
Novartis Bioventures Ltd10% OwnerJul 16Sale5.153001,5452,543,882Jul 18 04:17 PM
Novartis Institutes for BioMed10% OwnerApr 23Buy15.00766,66611,499,9903,948,482Apr 23 04:43 PM